MI-induced up-regulation of fibrosis-related proteins; MMP2 and MMP9 were also suppressed by valsartan, indicating that valsartan may attenuate myocardial fibrosis after MI, consistent with in vitro results. Here, MMP9 is linked to myocardial infarction.